Project Grant HT9425261E299
Award Date 8/1/26
Completion Date 7/31/29
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
- Federal Grant Award Summary Case Western Reserve University's Office of Research Administration received a $839,998 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026 through June 30, 2028. The award supports research into pharmacological stabilization of the calpain-2 complex as a novel translational therapeutic approach for amyotrophic lateral sclerosis (ALS). This research initiative...
- Federal Grant Award Summary Case Western Reserve University's Office of Research Administration received a $402,500 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2027. The award supports research focused on repurposing an FDA (Food and Drug Administration)-approved drug to mitigate noise-induced hearing loss. This research initiative aligns with the DHA's mission to...
- Federal Project Grant Award Summary The Cleveland Clinic Foundation received a $559,992 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 30, 2025, with a completion date of September 29, 2028. The award supports bench-to-bedside development of superior CAR (Chimeric Antigen Receptor) T-cell therapy for leukemia, conducted at the organization's Cleveland, Ohio facility. This research initiative...
- Federal Grant Award Summary The Cleveland Clinic Foundation received a $750,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period April 1, 2026 through March 31, 2029. The project, titled "Leveraging Focal Adhesion Dependencies in CDH1-Deficient Lobular Breast Cancers," will be conducted at the organization's Cleveland, Ohio location. This award supports biomedical research designed to...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,163,218.00 to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) to conduct research on SLC37A3 as a novel prostate cancer target. The award period runs from July 15, 2024 to July 14, 2028. Through this funding, Case Western Reserve University will carry out...
- Federal Grant Award Summary The Cleveland Clinic Foundation received a $1.28 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2029. This four-year research award supports investigation of the biological mechanisms and therapeutic relevance of the SLC1A1 amino acid transporter in kidney cancer. The research will be conducted at the Cleveland Clinic Foundation's...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Cleveland Clinic Foundation a $999,566 project grant effective November 1, 2025, through October 31, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports a three-year research initiative focused on magnetic resonance imaging-guided transcriptomic analysis of spinal cord neurodegeneration and demyelination in multiple sclerosis. This project represents a hypothesis-driven...
- Federal Project Grant Award Summary The University of Cincinnati's Sponsored Research Services Division received a $817,828 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2028. This award supports research investigating nuclear translocation of mutant nuclear envelope proteins and their role in conferring G-CSF (granulocyte-colony stimulating factor) resistance in severe...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $213,501 Project Grant to University Health Network (UHN) under the Military Medical Research and Development program (CFDA 12.420) on October 1, 2025. The award funds a two-year research initiative through September 30, 2027, focused on identifying molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. This research will be conducted at UHN's facility in Ottawa, Ontario, Canada,...
- Federal Grant Award Summary The Cleveland Clinic Foundation received a $700,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2026 through April 30, 2030. The research initiative, titled "Deciphering the Role of the Gut and Tumor Microbiome on Ovarian Cancer Progression and Resistance to Chemotherapy," will be conducted at the awardee's Cleveland, Ohio facility. The project delivers...